Communiqués Genix Pharmaceuticals Corporation Toronto S.E.

Actions

GENX

CA0209261019

Produits pharmaceutiques

Temps Différé Toronto S.E. 23:00:00 04/10/2021			Varia. 5j.	Varia. 1 janv.
0,1700 ^CAD	-.--%		-.--%	-

27/06	Genix Pharmaceuticals Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 avril 2026	CI
26/03	Genix Pharmaceuticals Corporation publie ses résultats pour le premier trimestre clos le 31 janvier 2026	CI

Communiqués

06/05	Genix Pharmaceuticals Announces Change To CFO	AQ
07/10/25	Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms	NE
04/09/25	Genix Pharmaceuticals Closes Private Placement	NE
07/05/25	Genix Pharmaceuticals : NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS	PU
25/07/24	Genix Pharmaceuticals : Management’s Discussion and Analysis For the Six Months ended April 30, 2024	PU
25/07/24	Genix Pharmaceuticals : Condensed Interim Financial Statements For the Six Months ended April 30, 2024 and 2023	PU
04/07/24	Genix Pharmaceuticals : Management’s Discussion and Analysis	PU
04/07/24	Genix Pharmaceuticals : Condensed Interim Financial Statements	PU
06/02/24	Genix Announces TSX-V Approval of Warrant Amendments	NE
19/01/24	Genix Announces Warrant Repricing and Seeks Extension	NE
14/11/22	Genix Pharmaceuticals : Announces Auditor Resignation	PU
21/07/22	Genix Proposes to Extend Warrants	AQ
29/06/22	Genix Pharmaceuticals : MD&A ending April 30, 2022	PU
27/04/22	Genix Pharmaceuticals : - Form of Proxy	PU
27/04/22	Genix Pharmaceuticals : - Notice and Information Circular	PU
09/09/21	Genix Pharmaceuticals Corp :oration Receives Natural Product Number for Rechlor from Health Canada	AQ
15/07/21	Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License	NE
21/06/21	Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange	NE
07/06/21	Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders	NE
01/04/21	Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada's First Generic Thyroid Medication	NE
22/03/21	Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions (ANDS) for Its First Ten Ophthalmic Drugs with Health Canada	NE
22/09/20	Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director	NE
06/08/20	Genix Pharmaceuticals Corporation Announces Closing of Second Tranche Financing and Closing of Acquisition of Rights to Nutraceutical Products Sucanon(R) and Renochlor(R)	NE
17/07/20	Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement	NE
01/07/20	Genix Pharmaceuticals Corporation Announces the Extension of Payment Terms for the Acquisitions of Rights to Renochlor(R), Sucanon(R) and Flu-x(TM)	NE